Results 201 to 210 of about 681,456 (227)
Some of the next articles are maybe not open access.
Consideration of the biosimilar drug lag and loss among Japan, the USA, and the EU
Naunyn-Schmiedeberg's Archives of PharmacologyAya Hariu +2 more
semanticscholar +1 more source
Healthcare system conversion to a biosimilar: Trials and tribulations
American Journal of Health-System Pharmacy, 2021Simon W Lam
exaly
Clinical safety of biosimilar recombinant human erythropoietins
Expert Opinion on Drug Safety, 2012Ivo Abraham, Karen Macdonald
exaly
Clinical safety of biosimilar recombinant human granulocyte colony-stimulating factors
Expert Opinion on Drug Safety, 2013Ivo Abraham, Karen Macdonald
exaly

